載入...

Autoantibody landscape in patients with advanced prostate cancer

BACKGROUND: Autoantibody responses in cancer are of great interest, as they may be concordant with T-cell responses to cancer antigens or predictive of response to cancer immunotherapies. Thus, we sought to characterize the antibody landscape of metastatic castration-resistant prostate cancer (mCRPC...

全面介紹

Na minha lista:
書目詳細資料
發表在:Clin Cancer Res
Main Authors: Chen, William S., Haynes, Winston A., Waitz, Rebecca, Kamath, Kathy, Vega-Crespo, Agustin, Shrestha, Raunak, Zhang, Minlu, Foye, Adam, Carretero, Ignacio Baselga, Perez, Ivan Garcilazo, Zhang, Meng, Zhao, Shuang G., Sjöström, Martin, Quigley, David A., Chou, Jonathan, Beer, Tomasz M., Rettig, Matthew, Gleave, Martin, Evans, Christopher P., Lara, Primo, Chi, Kim N., Reiter, Robert E., Alumkal, Joshi J., Ashworth, Alan, Aggarwal, Rahul, Small, Eric J., Daugherty, Patrick S., Ribas, Antoni, Oh, David Y., Shon, John C., Feng, Felix Y.
格式: Artigo
語言:Inglês
出版: 2020
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7710628/
https://ncbi.nlm.nih.gov/pubmed/32967941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-1966
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!